Non-invasive diagnosis of upper airway malignancies based on the analysis of markers in exhaled air
https://doi.org/10.21294/1814-4861-2023-22-6-7-15
Abstract
The purpose of the study was to evaluate diagnostic capabilities of the gas analysis sensor device used for the study of exhaled gas samples obtained from patients with oropharyngeal and laryngeal cancers.
Material and Methods. Exhaled gas samples from 31 oropharyngeal and laryngeal cancer patients and 31 healthy volunteers were studied using a diagnostic device based on the detection of volatile compounds in inhaled air using semiconductor gas sensors with subsequent neural network analysis.
Results. Based on the signals from gas sensors, the neural network classified and identified patients with malignant neoplasms. The sensitivity and specificity of the method were 67.74% and 87.1%, respectively.
Conclusion. The gas analysis sensor device and the method for detecting oropharyngeal and laryngeal tumors using the exhaled gas analysis are an accessible and cheap diagnostic tools, and are promising for screening the population in order to select individuals for a comprehensive examination (endoscopic, radiological and morphological) in identifying suspicion of cancer.
Keywords
About the Authors
D. E. KulbakinRussian Federation
Denis E. Kulbakin - MD, DSc, Head of Department of Head and Neck Tumors,
5, Kooperativny St., Tomsk, 634009
E. L. Choynzonov
Russian Federation
Evgeny L. Choynzonov - MD, DSc, Professor, Member of the Russian Academy of Sciences, Director,
5, Kooperativny St., Tomsk, 634009
I. K. Fedorova
Russian Federation
Irina K. Fedorova - MD, Postgraduate, Department of Head and Neck Tumors,
5, Kooperativny St., Tomsk, 634009
E. V. Obkhodskaya
Russian Federation
Elena V. Obkhodskaya - PhD, Senior Researcher, Laboratory of Chemical Technologies, Chemical faculty,
36, Lenina St., Tomsk, 634050
A. V. Obkhodskiy
Russian Federation
Artem V. Obkhodskiy - PhD, Associate Professor, School of Nuclear Technology,
30, Lenin St., Tomsk, 634050
E. O. Rodionov
Russian Federation
Evgeniy O. Rodionov - MD, PhD, Senior Researcher, Department of Thoracic Oncology, 5, Kooperativny St., Tomsk, 634009;
Assistant, Department of Oncology, 2, Moskovsky trakt, Tomsk, 634050
V. I. Sachkov
Russian Federation
Victor I. Sachkov - DSc, Head of the Laboratory of Chemical Technologies, Chemical faculty,
36, Lenina St., Tomsk, 634050
V. I. Chernov
Russian Federation
Vladimir I. Chernov - MD, DSc, Professor, Deputy Director for Science and Innovation, Head of Nuclear Medicine Department,
5, Kooperativny St., Tomsk, 634009
References
1. Cancer care for the population of Russia in 2021. Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2022. 239 p. (in Russian).
2. Panferova O.I., Nikolenko V.N., Kochurova E.V., Kudasova E.O. Etiology, pathogenesis, basic principles of treatment of squamous cell carcinoma of the oral mucosa. Head and neck. Russian Journal. 2022; 10(2): 69–77. (in Russian). doi: 10.25792/HN.2022.10.2.69-77.
3. The National Comprehensive Cancer Network [Internet]. Clinical Practice Guidelines in Oncology. [cited 2023 May 15]. URL: https://www.nccn.org/professionals/physician_gls/default.aspx.
4. Harris A., Lyu L., Wasserman-Winko T., George S., Johnson J.T., Nilsen M.L. Neck Disability and Swallowing Function in Posttreatment Head and Neck Cancer Patients. Otolaryngol Head Neck Surg. 2020; 163(4): 763–70. doi: 10.1177/0194599820923630.
5. Krilaviciute A., Stock C., Leja M., Brenner H. Potential of noninvasive breath tests for preselecting individuals for invasive gastric cancer screening endoscopy. J. Breath Res. 2018; 12. doi: 10.1088/1752-7163/aab5be.
6. Bouza M., Gonzalez-Soto J., Pereiro R., de Vicente J.C., SanzMedel A. Exhaled breath and oral cavity VOCs as potential biomarkers in oral cancer patients. J Breath Res. 2017; 11(1). doi: 10.1088/1752-7163/aa5e76.
7. Leunis N., Boumans M.L., Kremer B., Din S., Stobberingh E., Kessels A.G., Kross K.W. Application of an electronic nose in the diagnosis of head and neck cancer. Laryngoscope. 2014; 124(6): 1377–81. doi: 10.1002/lary.24463.
8. Opitz P., Herbarth O. The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC). J Otolaryngol Head Neck Surg. 2018; 47(1): 42. doi: 10.1186/s40463-018-0288-5.
9. Chernov V.I., ChoynzonovE.L., KulbakinD.E., Obkhodskaya E.V., Obkhodskiy A.V., Popov A.S., Sachkov V.I., Sachkova A.S. Cancer Diagnosis by Neural Network Analysis of Data from Semiconductor Sensors. Diagnostics. 2020; 10(9). doi: 10.3390/diagnostics10090677.
10. Horváth I., Barnes P.J., Loukides S., Sterk P.J., Högman M., Olin A.C., Amann A., Antus B., Baraldi E., Bikov A., Boots A.W., Bos L.D., Brinkman P., Bucca C., Carpagnano G.E., Corradi M., Cristescu S., de Jongste J.C., Dinh-Xuan A.T., Dompeling E., Fens N., Fowler S., Hohlfeld J.M., Holz O., Jöbsis Q., Van De Kant K., Knobel H.H., Kostikas K., Lehtimäki L., Lundberg J., Montuschi P., Van Muylem A., Pennazza G., Reinhold P., Ricciardolo F.L.M., Rosias P., Santonico M., van der Schee M.P., van Schooten F.J., Spanevello A., Tonia T., Vink T.J. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017; 49(4). doi: 10.1183/13993003.00965-2016.
11. Shakeel P.M., Tolba A., Al-Makhadmeh Z., Jaber M.M. Automatic detection of lung cancer from biomedical data set using discrete AdaBoost optimized ensemble learning generalized neural networks. Neural Computing and Applications. 2020; 32: 777–90.
12. Becker M., Zaidi H. Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI. Br J Radiol. 2014; 87(1036). doi: 10.1259/bjr.20130677.
Review
For citations:
Kulbakin D.E., Choynzonov E.L., Fedorova I.K., Obkhodskaya E.V., Obkhodskiy A.V., Rodionov E.O., Sachkov V.I., Chernov V.I. Non-invasive diagnosis of upper airway malignancies based on the analysis of markers in exhaled air. Siberian journal of oncology. 2023;22(6):7-15. (In Russ.) https://doi.org/10.21294/1814-4861-2023-22-6-7-15